How GW Pharma Won CBD

As of this writing, GW Pharma’s CBD drug Epidiolex has been approved for treating profound refractory pediatric epilepsy syndromes (Dravet syndrome and Lennox Gastaut syndrome) as well as seizures associated with tuberous sclerosis complex (TSC) in patients one year of age or older.  The product is a very simple, orally-administered formulation comprised of 100mg/ml cannabidiol